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Short Report
Upper limb entrapment neuropathies in multiple
sclerosis
Han Yin, Krishnan PS Nair , Dasappaiah G Rao, Sankaranarayanan Hariharan, Amy Spencer and
Kathleen Baster
Abstract
Introduction: Entrapment neuropathies of upper limbs such as carpal tunnel and cubital tunnel syn-
dromes are common in the general population. Identification of entrapment neuropathies of upper limbs
in patients with multiple sclerosis can be clinically challenging as signs and symptoms could be attrib-
uted to multiple sclerosis. People at later stages of multiple sclerosis use mobility aids and wheelchairs.
Weakness of hands in this cohort due to entrapment neuropathies could adversely affect their mobility
and independence.
Methods: This was a retrospective review of records of patients with multiple sclerosis referred for
clinical neurophysiological studies with clinical suspicion of upper limb entrapment neuropathies over a
10-year period. We collected demographic details, clinical features, clinical neurophysiological data and
details of aids and appliances used for mobility.
Results: Among 71 patients, 38 (53.5%) patients had at least one entrapment neuropathy of upper limb
confirmed by clinical neurophysiological studies. Twelve (31%) patients had median nerve entrapment,
20 (53%) had ulnar nerve entrapment and six (16%) had both. Risk of ulnar nerve entrapment was
significantly higher in patients using a powered wheelchair (odds ratio 5.7, 95% confidence interval
(1.7–18.7, p¼ 0.0037).
Discussion: Entrapment neuropathies should be considered in patients with multiple sclerosis reporting
sensory and motor symptoms of hands.
Keywords: Multiple sclerosis, rehabilitation, upper limb, entrapment neuropathies, carpal tunnel syn-
drome, cubital tunnel syndrome.
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Introduction
Multiple sclerosis (MS) is an immune -mediated dis-
order of the central nervous system causing sensory
disturbances, motor weakness and autonomic symp-
toms like problems with control of bowel and blad-
der. The prevalence of peripheral neuropathy in
MS is around 5.8% and is usually attributed to nutri-
tional factors, cytotoxic drugs or independent con-
comitant conditions such as diabetes.1,2
Entrapment neuropathies (EN) are caused by the
chronic focal compression of a peripheral nerve.
Carpal tunnel syndrome (CTS), caused by the
entrapment of the median nerve in the carpal
tunnel, is the most common entrapment neuropathy
with a prevalence of 2.7% in the general popula-
tion.3 It is characterised by numbness, tingling,
pain and weakness of the hand. Cubital tunnel syn-
drome (CuTS) is caused by entrapment of the ulnar
nerve as it passes behind the medial epicondyle of
the humerus. The prevalence of CuTS in the general
population is 1.8%.4,5 Use of mobility aids is a risk
factor for entrapment neuropathies of the upper
limbs.6
People with moderate to severe forms of MS often
use mobility aids like crutches, sticks and wheel-
chairs. Clinical recognition of entrapment
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neuropathies in patients with MS can be challenging
as their signs and symptoms could be masked by
those of MS. Clinical neurophysiological studies
could help to diagnose the median and ulnar entrap-
ment neuropathies. Prompt diagnosis and interven-
tion for entrapment neuropathy could potentially
preserve hand function. Our search of PubMed
with key words ‘multiple sclerosis’, ‘entrapment
neuropathies’, ‘ulnar nerve’, ‘median nerve’,
‘carpal tunnel syndrome’ and ‘cubital tunnel syn-
drome’ did not identify any studies on entrapment
neuropathies in people with MS.
This is a retrospective clinical records review of
people with MS who underwent clinical neurophys-
iological studies for CTS and CuTS.
Methods
We reviewed records of all patients with MS who
were referred for clinical neurophysiological studies
with suspected upper limb entrapment neuropathies
from 2007–2016. We recorded age, gender, type of
MS, duration since diagnosis of MS, Extended
Disability Status Scale (EDSS) score, clinical diag-
nosis of entrapment neuropathy and use of mobility
aids. All clinical neurophysiological studies were
carried out as per the recommendations from the
British Society for Clinical Neurophysiology.7
We obtained the approval of the clinical effective-
ness unit of the Sheffield Teaching Hospitals NHS
Foundation Trust for this study (STHCEU project
number: 5494).
Results
The age, gender, duration of MS, type of MS and
EDSS of the 71 patients are shown in Table 1.
Thirty-seven patients (52%) presented with bilateral
hand symptoms. Clinical neurophysiological studies
confirmed at least one entrapment neuropathy in
38/71 patients (53.5%). The clinical neurophysio-
logical studies confirmed CTS in 12 of
14(85.71%) patients with the clinical diagnosis of
CTS. The clinical neurophysiological studies also
confirmed CuTS in 20 of 27 (74%) patients with
the clinical suspicion of CuTS. In 10 patients both
CTS and CuTS were suspected clinically and clini-
cal neurophysiological studies confirmed both in six
(60%) patients. Thirty-three of 71 patients with clin-
ical suspicion of CTS, CuTS or both (46.47%) did
not have either condition on clinical neurophysiolog-
ical studies. Surgical decompression was offered to
21/38 (55.2%) and was done in 17/38 (44.7%).
Twelve out of 17 (70.6%) patients had surgical
decompression for ulnar nerve entrapment and 5/17
(29.4%) had median entrapment.
All except two patients required mobility aids.
The types of aids are shown in Table 2. Among 33
patients using a powered wheelchair 18 had CuTS.
Only eight of the 38 patients who were not using
powered wheelchairs had CuTS. The use of powered
wheelchairs significantly increased the risk of CuTS
in patients with MS (odds ratio (OR) 5.7, 95% con-
fidence interval (CI) –1.7–18.7, p¼ 0.0037).
Subjects who had either CTS or CuTS had a higher
mean age of 61.7 years compared to subjects
who did not have either (mean age of 56.2 years)
(t¼ –2.079, p¼ 0.042). Overall, 20/27 men (74.1%)
and 18/44 women (40.9%) had either CTS or CuTS
(Chi-squared test v2¼ 6.125 and p¼ 0.013). Among
the 52 subjects, those who had an EN had a mean
disease duration of 25.1 years, whereas subjects who
did not have an EN had a mean disease duration of
15.8 years (t-test¼ –2.626, p¼ 0.012). We did not
have reliable data on the duration of MS in
19 patients.
The prevalence of CuTS was higher in men (18/27)
than in women (8/44) (Chi-squared test v2¼ 14.923,
p< 0.001). Among those subjects with CuTS, the
mean age was 60.0 years, and among those without
Table 1. Demographics and clinical features.
Age (mean) 59.1 11.3 years (range: 34–82 years)
Gender
Women 44
Men 27
Duration of multiple sclerosis (mean) 20.8 14.8 years (range: 0–60 years)
Type of multiple sclerosis
Remitting–relapsing 2
Secondary progressive 68
Primary progressive 1
Extended Disability Status Scale (median) 7.5 (range: 5.5–7.5)
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it was 58.7 years (t-test¼ –0.473 and p¼ 0.638).
Subjects who had CuTS had a mean disease duration
of 22.5 years, whereas subjects who did not have
CuTS had a mean disease duration of 19.8 years
(Wilcoxon rank sum test W-statistic¼ 264,
p¼ 0.296).
Overall, 8/27 men and 10/44 women had CTS
(Chi-squared test v2¼ 0.135, p¼ 0.713). The sub-
jects with CTS had a mean age of 64.0 years,
and among those without it was 57.5 years
(t-test¼ –2.327, p¼ 0.026). Subjects who had CTS
had a mean disease duration of 27.0 years, whereas
subjects who did not have CTS had a mean disease
duration of 19.0 years (Wilcoxon rank sum test
W-statistic¼ 191.5, p¼ 0.297).
Discussion
Around 66% of people with MS have upper limb
motor impairments that could affect daily living
activities.8 Concomitant CTS or CuTS could aggra-
vate this hand dysfunction and contribute to the
limitation of activities. Our data suggest that a pro-
portion of hand problems in patients with MS could
be due to CTS, CuTS or both. While CTS is more
prevalent in the general population, our results
show that CuTS was more prevalent in the patients
with MS.3
We noted that the risk of developing CuTS was five
times higher among people with MS using powered
wheelchairs compared to those using other mobility
aids or no mobility aids. The ulnar nerve while pass-
ing through the cubital tunnel at elbow is susceptible
to injury due to compression and traction. The
distance between the medial epicondyle and the
olecranon increases by 5 mm for every 45 of
elbow flexion.9,10 During elbow flexion the shape
of the cubital tunnel in cross-section changes from
round to oval, with a loss of height of 2.5 mm and
reduction of volume by 55%. Cadaveric studies
have shown that the tissue pressure on the ulnar
nerve in the cubital tunnel rose from 7mmHg to
11–24mmHg when the elbow was flexed to
90 degrees.9,10 While seated in a power wheel
chair, the upper limb assumes a position of shoulder
abduction, elbow flexion and wrist extension which
results in traction of the ulnar nerve. Prolonged sit-
ting on a powered wheelchair with the elbow flexed
and pressed down on the arm rest can cause traction
and chronic pressure on the ulnar nerve resulting
in CuTS.
People who used a cane/crutch were at increased risk
of CTS.6 Among 22 of our patients using stick,
crutches or frames, seven had CTS (Table 2).
Focal compression of median nerve in the carpal
tunnel at wrist while walking with a stick, frame
or crutches could be causing CTS in these patients.
Entrapment neuropathies of the upper limb were
more frequent among men, those of older age and
people with a longer duration of MS. CuTS was
more common among men. The mean age of
people with CTS was significantly higher than
those without CTS. Most of our patients (68/71)
were in the secondary progressive phase of MS.
A larger study with more patients with remitting–
relapsing MS (RRMS) and primary progressive
MS (PPMS) may help to answer the question as to
whether entrapment neuropathies are more common
in any particular type of MS.
Limitations
This report is based on the retrospective collection of
data and as such has several limitations. We did not
collect data on handedness, hand used for controlling
the powered wheelchair, duration of use of the pow-
ered wheelchair and functional outcomes after sur-
gical management. We did not have the data on
Table 2. Use of mobility aids and entrapment neuropathies in patients with MS.
Mobility aid Number of patients CTS CuTS Both None
Powered wheel chair 33 1 16 2 14
Manual wheel chair 5 1 1 1 2
Crutches 7 1 3 0 3
Frame 8 2 0 0 6
Stick 7 4 0 0 3
No aids 2 1 0 0 1
Data not available 9 2 0 3 4
CTS: carpal tunnel syndrome; CuTS: cubital tunnel syndrome.
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other conditions that can cause entrapment neurop-
athies in this cohort. We also did not collect the
duration of hand symptoms and whether the diagno-
sis was potentially missed during earlier consulta-
tions. Although the p-values for gender, age and
duration of MS are below the usual 5% significance
level, because this is a secondary analysis the results
should only be used to inform future areas of
research rather than to make any bold claims about
the relationship between gender, age, duration of MS
and entrapment neuropathy.
Conclusions
CuTS and CTS should be considered in patients with
advanced MS using mobility aids and experiencing
sensory and motor symptoms of hands. Patients with
MS using powered wheel chairs are more at risk of
developing CuTS.
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